Colreavy M P, Lacy P D, Hughes J, Bouchier-Hayes D, Brennan P, O'Dwyer A J, Donnelly M J, Gaffney R, Maguire A, O'Dwyer T P, Timon C V, Walsh M A
Department of Otolaryngology-Head and Neck Surgery Beaumont Hospital, Dublin, Ireland.
J Laryngol Otol. 2000 Feb;114(2):119-24. doi: 10.1258/0022215001905058.
Schwannomas of the head and neck are uncommon tumours that arise from any peripheral, cranial or autonomic nerve. Twenty-five to 45 per cent of extracranial schwannomas occur in the head and neck region and thus are usually in the domain of the otolaryngologist. They usually present insidiously and thus are often diagnosed incorrectly or after lengthy delays, however, better imaging and cytological techniques have lessened this to some degree more recently. For benign lesions conservative surgical excision is the treatment of choice bearing in mind possible vagal or sympathetic chain injury. Malignant schwannomas are best treated with wide excision where possible. The role of adjuvant therapy remains uncertain and irrespective of treatment modality prognosis is poor with an overall survival of 15 per cent. However, recent advances in ras oncogene inhibitors may hold hope for the future.
头颈部神经鞘瘤是一种罕见的肿瘤,起源于任何外周神经、颅神经或自主神经。25%至45%的颅外神经鞘瘤发生在头颈部区域,因此通常属于耳鼻喉科医生的诊疗范围。它们通常隐匿起病,因此常常被误诊或延误很长时间才得以诊断,不过,近年来更好的影像学和细胞学技术在一定程度上减少了这种情况的发生。对于良性病变,考虑到可能损伤迷走神经或交感神经链,保守性手术切除是首选治疗方法。恶性神经鞘瘤尽可能采用广泛切除的方法进行治疗。辅助治疗的作用仍不明确,无论采用何种治疗方式,预后都很差,总体生存率为15%。然而,ras癌基因抑制剂方面的最新进展可能为未来带来希望。